1
|
Hauguel C, Ducellier S, Provot O, Ibrahim N, Lamaa D, Balcerowiak C, Letribot B, Nascimento M, Blanchard V, Askenatzis L, Levaique H, Bignon J, Baschieri F, Bauvais C, Bollot G, Renko D, Deroussent A, Prost B, Laisne MC, Michallet S, Lafanechère L, Papot S, Montagnac G, Tran C, Alami M, Apcher S, Hamze A. Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors. Eur J Med Chem 2022; 240:114573. [DOI: 10.1016/j.ejmech.2022.114573] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 06/23/2022] [Accepted: 06/24/2022] [Indexed: 11/04/2022]
|
2
|
Hauguel C, Tran C, Provot O, Bignon J, gandon V, HAMZE A. Water‐Facilitated Nitromethane‐Mediated Cyclization of 2‐(Phenylvinyl)benzhydrols: Access to 1,3‐Diphenyl‐1H‐indenes with Antitumor Activity. Adv Synth Catal 2022. [DOI: 10.1002/adsc.202200550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
3
|
Zhang K, Provot O, Alami M, Tran C, Hamze A. Pd-Catalyzed Coupling of N-Tosylhydrazones with Benzylic Phosphates: Toward the Synthesis of Di- or Tri-Substituted Alkenes. J Org Chem 2022; 87:1249-1261. [PMID: 35015524 DOI: 10.1021/acs.joc.1c02580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
This study shows that various di- and tri-substituted alkenes with high chemoselectivity were obtained in good to high yields by coupling N-tosylhydrazones (NTHs) with benzylic phosphates as electrophilic partners. The obtained new catalytic system consisted of PdCl2(CH3CN)2/dppp, LiOtBu as a base, and cyclopentyl methyl ether as a green solvent. In addition, we performed a gram-scale transformation using NTH derivatives and benzylic phosphates having a C sp2-Cl bond. The latter was used as a starting point for further postfunctionalization of the key intermediates.
Collapse
Affiliation(s)
- Kena Zhang
- Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France
| | - Olivier Provot
- Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France
| | - Mouad Alami
- Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France
| | - Christine Tran
- Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France
| | - Abdallah Hamze
- Université Paris-Saclay, CNRS, BioCIS, 92290 Châtenay-Malabry, France
| |
Collapse
|
4
|
Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues. Eur J Med Chem 2021; 223:113656. [PMID: 34171660 DOI: 10.1016/j.ejmech.2021.113656] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 06/14/2021] [Accepted: 06/14/2021] [Indexed: 12/19/2022]
Abstract
In this study, a variety of original ligands related to Combretastatin A-4 and isoCombretastatin A-4, able to inhibit the tubulin polymerization into microtubules, was designed, synthesized, and evaluated. Our lead compound 15d having a quinazoline as A-ring and a 2-substituted indole as B-ring separated by a N-methyl linker displayed a remarkable sub-nanomolar level of cytotoxicity (IC50 < 1 nM) against 9 human cancer cell lines.
Collapse
|
5
|
Faouzi A, Arnaud A, Bancet A, Barette C, Preto J, Do CV, Jordheim LP, Bousfiha Z, Nguyen TTB, Verrière M, Farce A, Fauvarque MO, Barret R, Lomberget T. Combretastatin A-4 sulfur-containing heterocyclic derivatives: Synthesis, antiproliferative activities and molecular docking studies. Eur J Med Chem 2021; 215:113275. [PMID: 33618157 DOI: 10.1016/j.ejmech.2021.113275] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 01/30/2021] [Accepted: 01/31/2021] [Indexed: 12/24/2022]
Abstract
Combretastatin A-4 inspired heterocyclic derivatives were synthesized and evaluated for their biological activities on tubulin polymerization and cell proliferation. Among the 19 described sulfur-containing compounds, derivatives (Z)-4h and (Z)-4j exhibited interesting in cellulo tubulin polymerization inhibition and antiproliferative activities with IC50 values for six different cell lines between 8 and 27 nM. Furthermore, in silico docking studies within the colchicine/CA-4 binding site of tubulin were carried out to understand the interactions of our products with the protein target. The effects on the cell cycle of follicular lymphoma cells were also investigated at 1-10 nM concentrations showing that apoptotic processes occurred.
Collapse
Affiliation(s)
- Abdelfattah Faouzi
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France; Present Address: Center for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, MO, USA
| | - Alexandre Arnaud
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France
| | - Alexandre Bancet
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France
| | - Caroline Barette
- Univ. Grenoble Alpes, CEA, Inserm, BGE U1038, 38000, Grenoble, France
| | - Jordane Preto
- Université de Lyon, Université Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, 69008, France
| | - Cong Viet Do
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France; University of Science and Technology of HanoÏ USTH, 18 Hoang Quoc Viet, Hanoi, 100000, Viet Nam; Present Address: Faculty of Pharmacy, Dai Nam University, 56 Vu Trong Phung, Hanoi, Viet Nam
| | - Lars Petter Jordheim
- Université de Lyon, Université Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, 69008, France
| | - Zineb Bousfiha
- Université de Lyon, Université Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, 69008, France
| | - Thi Thanh Binh Nguyen
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France; Present Address: VNU School of Medicine and Pharmacy, 144 Xuan Thuy, Cau Giay, Hanoi, 100000, Viet Nam
| | - Marion Verrière
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France
| | - Amaury Farce
- Université de Lille, Inserm, CHU Lille, U995, LIRIC, Lille Inflammation Research International Center, F-59006 Lille Cedex, France
| | | | - Roland Barret
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France
| | - Thierry Lomberget
- Université de Lyon, Université Lyon 1, Faculté de Pharmacie, ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453, INSERM US7, F-69373, Lyon Cedex 08, France; Université de Lyon, Université Lyon 1, CNRS UMR 5246 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS), Faculté de Pharmacie, ISPB, 8, Avenue Rockefeller, F-69373, Lyon, Cedex 08, France.
| |
Collapse
|
6
|
Lawal B, Liu YL, Mokgautsi N, Khedkar H, Sumitra MR, Wu ATH, Huang HS. Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines. Biomedicines 2021; 9:biomedicines9010092. [PMID: 33477856 PMCID: PMC7832910 DOI: 10.3390/biomedicines9010092] [Citation(s) in RCA: 41] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2020] [Revised: 01/16/2021] [Accepted: 01/18/2021] [Indexed: 12/11/2022] Open
Abstract
Signal transducer and activator of transcription 3 (STAT3) is a transcriptional regulator of a number of biological processes including cell differentiation, proliferation, survival, and angiogenesis, while cyclin-dependent kinases (CDKs) are a critical regulator of cell cycle progression. These proteins appear to play central roles in angiogenesis and cell survival and are widely implicated in tumor progression. In this study, we used the well-characterized US National Cancer Institute 60 (NCI60) human tumor cell lines to screen the in vitro anti-cancer activities of our novel small molecule derivatives (NSC765690 and NSC765599) of salicylanilide. Furthermore, we used the DTP-COMPARE algorithm and in silico drug target prediction to identify the potential molecular targets, and finally, we used molecular docking to assess the interaction between the compounds and prominent potential targets. We found that NSC765690 and NSC765599 exhibited an anti-proliferative effect against the 60 panels of NCI human cancer cell lines, and dose-dependent cytotoxic preference for NSCLC, melanoma, renal, and breast cancer cell lines. Protein–ligand interactions studies revealed that NSC765690 and NSC765599 were favored ligands for STAT3/CDK2/4/6. Moreover, cyclization of the salicylanilide core scaffold of NSC765690 mediated its higher anti-cancer activities and had greater potential to interact with STAT3/CDK2/4/6 than did NSC765599 with an open-ring structure. NSC765690 and NSC765599 met the required safety and criteria of a good drug candidate, and are thus worthy of further in-vitro and in-vivo investigations in tumor-bearing mice to assess their full therapeutic efficacy.
Collapse
Affiliation(s)
- Bashir Lawal
- PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; (B.L.); (N.M.); (H.K.); (M.R.S.)
- Graduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
| | - Yen-Lin Liu
- Department of Pediatrics, Taipei Medical University Hospital, Taipei 11031, Taiwan;
- Taipei Cancer Center, Taipei Medical University, Taipei 11031, Taiwan
- Department of Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
- TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan
| | - Ntlotlang Mokgautsi
- PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; (B.L.); (N.M.); (H.K.); (M.R.S.)
- Graduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
| | - Harshita Khedkar
- PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; (B.L.); (N.M.); (H.K.); (M.R.S.)
- Graduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
| | - Maryam Rachmawati Sumitra
- PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; (B.L.); (N.M.); (H.K.); (M.R.S.)
- Graduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
| | - Alexander T. H. Wu
- TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan
- The PhD Program of Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
- Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
- Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan
- Correspondence: (A.T.H.W.); (H.-S.H.)
| | - Hsu-Shan Huang
- PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan; (B.L.); (N.M.); (H.K.); (M.R.S.)
- Graduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan
- Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan
- School of Pharmacy, National Defense Medical Center, Taipei 11490, Taiwan
- PhD Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan
- Correspondence: (A.T.H.W.); (H.-S.H.)
| |
Collapse
|
7
|
Pecnard S, Provot O, Levaique H, Bignon J, Askenatzis L, Saller F, Borgel D, Michallet S, Laisne MC, Lafanechère L, Alami M, Hamze A. Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation. Eur J Med Chem 2020; 209:112873. [PMID: 33038796 DOI: 10.1016/j.ejmech.2020.112873] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 09/21/2020] [Accepted: 09/21/2020] [Indexed: 12/14/2022]
Abstract
In this work, a series of cyclic bridged analogs of isocombretastatin A-4 (isoCA-4) with phenyl or pyridine linkers were designed and synthesized. The synthesis of the desired analogs was performed by the formation of nitro-vinyl intermediates, followed by a Cadogan cyclization. Structure activity relationship (SAR) study demonstrates the critical role of the combination of quinaldine as ring A, pyridine as the linker, and indole as ring B in the same molecule, for the cytotoxic activity. Among all tested compounds, compound 42 showed the highest antiproliferative activity against a panel of cancer cell lines with average IC50 values of 5.6 nM. Also, compound 42 showed high antiproliferative activity against the MDR1-overexpressing K562R cell line; thus, it was 1.5- and 12-fold more active than the reference compounds, isoCA-4 and CA-4, respectively. Moreover, 42 displayed a strong antiproliferative activity against the colon-carcinoma cells (HT-29), which are resistant to combretastatin A-4 and isoCA-4, and it was found to be 8000-fold more active than natural CA-4. Compound 42 also effectively inhibited tubulin polymerization both in vitro and in cells, and induced cell cycle arrest in G2/M phase. Next, we demonstrated that compound 42 dose-dependently caused caspase-induced apoptosis of K562 cells through mitochondrial dysfunction. Finally, we evaluated the effect of compound 42 in human no cancer cells compared to the reference compound. We demonstrated that 42 was 73 times less cytotoxic than isoCA-4 in quiescent peripheral blood lymphocytes (PBLs). In summary, these results suggest that compound 42 represents a promising tubulin inhibitor worthy of further investigation.
Collapse
Affiliation(s)
- Shannon Pecnard
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Olivier Provot
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Hélène Levaique
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, F-91198, Gif sur Yvette, France
| | - Jérome Bignon
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, F-91198, Gif sur Yvette, France
| | - Laurie Askenatzis
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, F-91198, Gif sur Yvette, France
| | - Francois Saller
- INSERM, UMR-S1176, University Paris-Saclay, F-94276, Le Kremlin-Bicetre, France
| | - Delphine Borgel
- INSERM, UMR-S1176, University Paris-Saclay, F-94276, Le Kremlin-Bicetre, France
| | - Sophie Michallet
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Université Grenoble Alpes, Grenoble, France
| | - Marie-Catherine Laisne
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Université Grenoble Alpes, Grenoble, France
| | - Laurence Lafanechère
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Université Grenoble Alpes, Grenoble, France
| | - Mouad Alami
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Abdallah Hamze
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France.
| |
Collapse
|
8
|
Khelifi I, Pecnard S, Bernadat G, Bignon J, Levaique H, Dubois J, Provot O, Alami M. Synthesis and Anticancer Properties of Oxazepines Related to Azaisoerianin and IsoCoQuines. ChemMedChem 2020; 15:1571-1578. [PMID: 32485077 DOI: 10.1002/cmdc.202000197] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Indexed: 01/07/2023]
Abstract
In this article, we report the synthesis and biological properties of a series of novel oxazepines related to isoCA-4 having significant antitumor properties. Among them, three oxazepin-9-ol derivatives display a nanomolar or a sub-nanomolar cytotoxicity level against five human cancer cell lines (HCT116, U87, A549, MCF7, and K562). It was demonstrated that the lead compound in this series inhibits tubulin assembly with an IC50 value of 1 μM and totally arrests the cellular cycle in the G2/M phase at the low concentration of 5 nM in HCT116 and K562 cells. Molecular modeling studies perfectly corroborates these promising results.
Collapse
Affiliation(s)
- Ilhem Khelifi
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Shannon Pecnard
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | | | - Jérome Bignon
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la terrasse, 91198, Gif sur Yvette, France
| | - Hélène Levaique
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la terrasse, 91198, Gif sur Yvette, France
| | - Joëlle Dubois
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la terrasse, 91198, Gif sur Yvette, France
| | - Olivier Provot
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Mouad Alami
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| |
Collapse
|
9
|
Hamze A, Alami M, Provot O. Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents. Eur J Med Chem 2020; 190:112110. [PMID: 32061961 DOI: 10.1016/j.ejmech.2020.112110] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Revised: 01/29/2020] [Accepted: 01/29/2020] [Indexed: 10/25/2022]
Abstract
Combretastatin A-4 (CA-4) is a natural anti-cancer agent isolated in 1989 from the African willow tree, Combretum caffrum. Due to its chemical simplicity, this (Z)-stilbene has been the subject of many structural modifications mainly to improve its chemical and metabolic stability. Beside a large number of synthetic analogues, isoCombretastatin A-4 (isoCA-4), has proved to be a solution of choice since this non-natural isomer of CA-4 is stable, easier to synthesize and has equivalent antitumor properties as CA-4. In this review, we will present the structure-activity relationships (SARs) around isoCA-4 since its discovery in 2007. In a first part, we will describe some alternatives to replace the phenol B-ring of isoCA-4, then we will focus on the variations made on the 1,1-ethylene double bond and then, we will evocate very recent exiting results concerning the possible replacements of the 3,4,5-trimethoxyphenyl A-ring of isoCA-4 by suitable heterocycles.
Collapse
Affiliation(s)
- Abdallah Hamze
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France
| | - Mouad Alami
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France.
| | - Olivier Provot
- Université Paris-Saclay, CNRS, BioCIS, 92290, Châtenay-Malabry, France.
| |
Collapse
|
10
|
Khandaker TA, Hess JD, Aguilera R, Andrei G, Snoeck R, Schols D, Pradhan P, Lakshman MK. Synthesis and Evaluations of "1,4-Triazolyl Combretacoumarins" and Desmethoxy Analogues. European J Org Chem 2019; 2019:5610-5623. [PMID: 31579393 PMCID: PMC6774347 DOI: 10.1002/ejoc.201900569] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2019] [Indexed: 11/23/2022]
Abstract
1,4-Triazolyl combretacoumarins have been prepared by linking the trimethoxyarene unit of combretastatin A4 with coumarins, via a 1,2,3-triazole. For this, 4-azidocoumarins were accessed by a sequential two-step, one-pot reaction of 4-hydroxycoumarins with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP), followed by reaction with NaN3. In the reaction with BOP, a coumarin-derived phosphonium ion intermediate seems to form, leading to an O 4-(benzotriazolyl)coumarin derivative. For the CuAAC reaction of azidocoumarins with 5-ethynyl-1,2,3-trimethoxybenzene, catalytic [(MeCN)4Cu]PF6 in CH2Cl2/MeOH with 2,6-lutidine, at 50 °C, was suitable. The 4-azidocoumarins were less reactive as compared to PhN3 and the NBO coefficients of the azido groups were compared by DFT analysis. Compound solubility was a problem in biological assays. On the basis of the biological and solubility data of one 1,4-triazolyl combretacoumarin, four analogues lacking one or two methoxy groups were synthesized. Reactivity differences among the phenylacetylenes were noted and the NBO coefficients of the alkynes were compared by DFT analysis. In antiproliferative assays, 1-phenyl-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole showed activity in CEM and MDA-MB-231 cell lines, possibly by apoptosis. The desmethoxy 6-bromo-4-(4-(4-methoxyphenyl)-1H-1,2,3-triazol-1-yl)-2H-chromen-2-one also showed cytotoxicity against the two cell lines, but this did not appear to be consistent with apoptosis. The antiviral activity of the compounds was unremarkable.
Collapse
Affiliation(s)
- Tashrique A. Khandaker
- Department of Chemistry and BiochemistryThe City College of New York160 Convent AvenueNew YorkNY10031USA
| | - Jessica D. Hess
- Department of Biological SciencesBorder Biomedical Research CenterThe University of Texas at El PasoEl PasoTX79968USA
| | - Renato Aguilera
- Department of Biological SciencesBorder Biomedical Research CenterThe University of Texas at El PasoEl PasoTX79968USA
| | - Graciela Andrei
- Department of Microbiology and ImmunologyRega Institute of Medical ResearchHerestraat 49 – Box 10433000LeuvenLeuvenBelgium
| | - Robert Snoeck
- Department of Microbiology and ImmunologyRega Institute of Medical ResearchHerestraat 49 – Box 10433000LeuvenLeuvenBelgium
| | - Dominique Schols
- Department of Microbiology and ImmunologyRega Institute of Medical ResearchHerestraat 49 – Box 10433000LeuvenLeuvenBelgium
| | - Padmanava Pradhan
- Department of Chemistry and BiochemistryThe City College of New York160 Convent AvenueNew YorkNY10031USA
| | - Mahesh K. Lakshman
- Department of Chemistry and BiochemistryThe City College of New York160 Convent AvenueNew YorkNY10031USA
- The Ph.D. Program in ChemistryThe Graduate Center of the City University of New YorkNew YorkNY10016USA
| |
Collapse
|
11
|
Khelifi I, Naret T, Hamze A, Bignon J, Levaique H, Garcia Alvarez MC, Dubois J, Provot O, Alami M. N,N-bis-heteroaryl methylamines: Potent anti-mitotic and highly cytotoxic agents. Eur J Med Chem 2019; 168:176-188. [DOI: 10.1016/j.ejmech.2019.02.038] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2018] [Revised: 01/09/2019] [Accepted: 02/10/2019] [Indexed: 10/27/2022]
|
12
|
Khelifi I, Zhao G, Ghermani NE, Provot O, Alami M. Unexpected Oxidative Ring Opening of Electron-Rich 3-Aminobenzofurans into α-Ketoimines Derivatives. J Org Chem 2019; 84:1725-1733. [PMID: 30352149 DOI: 10.1021/acs.joc.8b01685] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
An unexpected ring opening of 3-aminobenzofurans promoted by NaO tBu in hot toluene, leading to a variety of α-ketoimines, is described. In the presence of 3-iodobenzofurans, NaO tBu mediates the 3-aminobenzofurans ring opening via a possible radical pathway without the help of any external radical sources.
Collapse
Affiliation(s)
- Ilhem Khelifi
- Univ. Paris-Sud, BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue Contre Le Cancer , F-92296 Châtenay-Malabry , France
| | - Guangkuan Zhao
- Univ. Paris-Sud, BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue Contre Le Cancer , F-92296 Châtenay-Malabry , France
| | - Nour-Eddine Ghermani
- Univ. Paris-Sud, Institut Galien Paris-Sud, CNRS, University Paris-Saclay , F-92296 Châtenay-Malabry , France
| | - Olivier Provot
- Univ. Paris-Sud, BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue Contre Le Cancer , F-92296 Châtenay-Malabry , France
| | - Mouad Alami
- Univ. Paris-Sud, BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue Contre Le Cancer , F-92296 Châtenay-Malabry , France
| |
Collapse
|
13
|
Naret T, Khelifi I, Provot O, Bignon J, Levaique H, Dubois J, Souce M, Kasselouri A, Deroussent A, Paci A, Varela PF, Gigant B, Alami M, Hamze A. 1,1-Diheterocyclic Ethylenes Derived from Quinaldine and Carbazole as New Tubulin-Polymerization Inhibitors: Synthesis, Metabolism, and Biological Evaluation. J Med Chem 2018; 62:1902-1916. [PMID: 30525602 DOI: 10.1021/acs.jmedchem.8b01386] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
We report the synthesis and metabolic and biological evaluation of a series of 17 novel heterocyclic derivatives of isocombretastatin-A4 (iso-CA-4) and their structure-activity relationships. Among these derivatives, the most active compound, 4f, inhibited the growth of a panel of seven cancer cell lines with an IC50 in the low nanomolar range. In addition, 4f showed interesting activity against CA-4-resistant colon-carcinoma cells and multidrug-resistant leukemia cells. It also induced G2/M cell-cycle arrest. Structural data indicated binding of 4f to the colchicine site of tubulin, likely preventing the curved-to-straight tubulin structural changes that occur during microtubule assembly. Also, 4f disrupted the blood-vessel-like assembly formed by human umbilical-vein endothelial cells in vitro, suggesting its function as a vascular-disrupting agent. An in vitro metabolism study of 4f showed its high human-microsomal stability in comparison with that of iso-CA-4. The physicochemical properties of 4f may be conducive to CNS permeability, suggesting that this compound may be a possible candidate for the treatment of glioblastoma.
Collapse
Affiliation(s)
- Timothée Naret
- BioCIS, Université Paris-Sud, CNRS, Équipe Labellisée Ligue Contre le Cancer , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Ilhem Khelifi
- BioCIS, Université Paris-Sud, CNRS, Équipe Labellisée Ligue Contre le Cancer , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Olivier Provot
- BioCIS, Université Paris-Sud, CNRS, Équipe Labellisée Ligue Contre le Cancer , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Jérôme Bignon
- CIBI Plateform , Institut de Chimie des Substances Naturelles, UPR 2301, CNRS , F-91198 Gif sur Yvette , France
| | - Hélène Levaique
- CIBI Plateform , Institut de Chimie des Substances Naturelles, UPR 2301, CNRS , F-91198 Gif sur Yvette , France
| | - Joelle Dubois
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS , F-91198 Gif sur Yvette , France
| | - Martin Souce
- Lip(Sys)2, Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Université Paris-Sud , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Athena Kasselouri
- Lip(Sys)2, Chimie Analytique Pharmaceutique (FKA EA4041 Groupe de Chimie Analytique de Paris-Sud), Université Paris-Sud , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Alain Deroussent
- UMR 8203, Laboratoire de Vectorologie et Thérapeutique Anticancéreuses, CNRS, Université Paris-Sud , Université Paris-Saclay, Gustave Roussy , F-94805 Villejuif , France
| | - Angélo Paci
- UMR 8203, Laboratoire de Vectorologie et Thérapeutique Anticancéreuses, CNRS, Université Paris-Sud , Université Paris-Saclay, Gustave Roussy , F-94805 Villejuif , France.,Department of Pharmacology and Drug Analysis, Gustave Roussy Cancer Campus Grand Paris , Université Paris-Sud , F-94805 Villejuif , France
| | - Paloma F Varela
- Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS , Université Paris-Sud, Université Paris-Saclay , F-91198 Gif-sur-Yvette , France
| | - Benoît Gigant
- Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS , Université Paris-Sud, Université Paris-Saclay , F-91198 Gif-sur-Yvette , France
| | - Mouad Alami
- BioCIS, Université Paris-Sud, CNRS, Équipe Labellisée Ligue Contre le Cancer , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| | - Abdallah Hamze
- BioCIS, Université Paris-Sud, CNRS, Équipe Labellisée Ligue Contre le Cancer , Université Paris-Saclay , F-92290 Châtenay-Malabry , France
| |
Collapse
|
14
|
Zhao G, Bignon J, Levaique H, Dubois J, Alami M, Provot O. One-Pot Synthesis of 2-Styrylindoles from Ortho-Substituted Chloroenynes. J Org Chem 2018; 83:15323-15332. [DOI: 10.1021/acs.joc.8b02563] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- Guangkuan Zhao
- Univ. Paris-Sud,
BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue
Contre Le Cancer, F-92296 Châtenay-Malabry, France
| | - Jerôme Bignon
- CIBI Platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Helène Levaique
- CIBI Platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Joëlle Dubois
- CIBI Platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Mouad Alami
- Univ. Paris-Sud,
BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue
Contre Le Cancer, F-92296 Châtenay-Malabry, France
| | - Olivier Provot
- Univ. Paris-Sud,
BioCIS, CNRS, University Paris-Saclay, Equipe Labellisée Ligue
Contre Le Cancer, F-92296 Châtenay-Malabry, France
| |
Collapse
|
15
|
Ibrahim N, Alami M, Messaoudi S. Recent Advances in Transition-Metal-Catalyzed Functionalization of 1-Thiosugars. ASIAN J ORG CHEM 2018. [DOI: 10.1002/ajoc.201800449] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Nada Ibrahim
- BioCIS, Univ. Paris-Sud; CNRS; University Paris-Saclay; 92290 Châtenay-Malabry France
| | - Mouad Alami
- BioCIS, Univ. Paris-Sud; CNRS; University Paris-Saclay; 92290 Châtenay-Malabry France
| | - Samir Messaoudi
- BioCIS, Univ. Paris-Sud; CNRS; University Paris-Saclay; 92290 Châtenay-Malabry France
| |
Collapse
|
16
|
Lamaa D, Lin HP, Zig L, Bauvais C, Bollot G, Bignon J, Levaique H, Pamlard O, Dubois J, Ouaissi M, Souce M, Kasselouri A, Saller F, Borgel D, Jayat-Vignoles C, Al-Mouhammad H, Feuillard J, Benihoud K, Alami M, Hamze A. Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4. J Med Chem 2018; 61:6574-6591. [DOI: 10.1021/acs.jmedchem.8b00050] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Diana Lamaa
- BioCIS, Univ. Paris-Sud, CNRS, équipe labellisée Ligue Contre le Cancer, Université Paris-Saclay, 92290 Châtenay-Malabry, France
| | - Hsin-Ping Lin
- BioCIS, Univ. Paris-Sud, CNRS, équipe labellisée Ligue Contre le Cancer, Université Paris-Saclay, 92290 Châtenay-Malabry, France
| | - Lena Zig
- Vectorologie et thérapeutiques anticancéreuses, UMR 8203 CNRS, Univ. Paris-Sud, Institut Gustave Roussy, Université
Paris-Saclay, Villejuif 94805, France
| | | | | | - Jérôme Bignon
- CIBI platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Helene Levaique
- CIBI platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Olivier Pamlard
- CIBI platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Joelle Dubois
- CIBI platform, Institut de Chimie des Substances Naturelles, UPR 2301, CNRS avenue de la terrasse, F-91198 Gif sur Yvette, France
| | - Mehdi Ouaissi
- CHRU Hôpital de Tours Trousseau, Service de chirurgie digestive, oncologique, endocrinienne et de transplantation hépatique, avenue de la République, 37170 Chambray-lès-Tours, France
| | - Martin Souce
- Lip(Sys)2, Chimie Analytique Pharmaceutique, Univ Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| | - Athena Kasselouri
- Lip(Sys)2, Chimie Analytique Pharmaceutique, Univ Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry, France
| | - François Saller
- INSERM, UMR-S1176, University Paris-Saclay, F-94276 Le Kremlin-Bicêtre, France
| | - Delphine Borgel
- INSERM, UMR-S1176, University Paris-Saclay, F-94276 Le Kremlin-Bicêtre, France
| | - Chantal Jayat-Vignoles
- Univ Limoges, Faculté de Médecine, CNRS UMR 7276, Laboratoire CRIBL, F-87025 Limoges, France
| | - Hazar Al-Mouhammad
- Univ Limoges, Faculté de Médecine, CNRS UMR 7276, Laboratoire CRIBL, F-87025 Limoges, France
| | - Jean Feuillard
- Univ Limoges, Faculté de Médecine, CNRS UMR 7276, Laboratoire CRIBL, F-87025 Limoges, France
- CHU Limoges, Hôpital Dupuytren, Service d’hématologie, F-87025 Limoges, France
| | - Karim Benihoud
- Vectorologie et thérapeutiques anticancéreuses, UMR 8203 CNRS, Univ. Paris-Sud, Institut Gustave Roussy, Université
Paris-Saclay, Villejuif 94805, France
| | - Mouad Alami
- BioCIS, Univ. Paris-Sud, CNRS, équipe labellisée Ligue Contre le Cancer, Université Paris-Saclay, 92290 Châtenay-Malabry, France
| | - Abdallah Hamze
- BioCIS, Univ. Paris-Sud, CNRS, équipe labellisée Ligue Contre le Cancer, Université Paris-Saclay, 92290 Châtenay-Malabry, France
| |
Collapse
|
17
|
Naret T, Bzeih T, Retailleau P, Alami M, Hamze A. One-Pot Selective Functionalization of Nitrogen-Containing Heterocycles with N
-tosylhydrazones and Amines. Adv Synth Catal 2017. [DOI: 10.1002/adsc.201701374] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Timothée Naret
- BioCIS; Equipe Labellisée Ligue Contre Le Cancer; Univ. Paris-Sud, CNRS; University Paris-Saclay Châtenay-Malabry 92290 France
| | - Tourin Bzeih
- BioCIS; Equipe Labellisée Ligue Contre Le Cancer; Univ. Paris-Sud, CNRS; University Paris-Saclay Châtenay-Malabry 92290 France
| | - Pascal Retailleau
- Institut de Chimie des Substances Naturelles; UPR 2301; CNRS Gif-sur-Yvette 91198 France
| | - Mouad Alami
- BioCIS; Equipe Labellisée Ligue Contre Le Cancer; Univ. Paris-Sud, CNRS; University Paris-Saclay Châtenay-Malabry 92290 France
| | - Abdallah Hamze
- BioCIS; Equipe Labellisée Ligue Contre Le Cancer; Univ. Paris-Sud, CNRS; University Paris-Saclay Châtenay-Malabry 92290 France
| |
Collapse
|
18
|
Liu H, Yu S, Peng Y, Chang X, Yu X. The protective effects of carboxyhemoglobin during the resuscitation from hemorrhagic shock in rats. Oncotarget 2017; 8:83619-83625. [PMID: 29137368 PMCID: PMC5663540 DOI: 10.18632/oncotarget.18768] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Accepted: 03/21/2017] [Indexed: 12/22/2022] Open
Abstract
Aim This study was aimed to explore the effects of carboxyhemoglobin on reperfusion injury in hemorrhagic shock, as well as its action time and related mechanisms. Results CO-RBC group showed milder oxidative injury than O2-RBC group. CO reperfusion did not show advantages in functions of kidney and lung during resuscitation. The level of Bax was decreased in CO-RBC group, especially in early CO-RBC group. Moreover, the autophay-related gene Beclin-1 was down-regulated in CO-RBC and early CO-RBC groups. The inflammation was severer in CO-RBC resuscitation group. Materials and Methods The hemorrhagic shock model rats were randomly divided into: the hemorrhagic shock group (n = 6); the O2-red blood cells (O2-RBC) group (n = 6), perfused with O2-RBC 1 h after ischemia; CO-RBC group (n = 12), perfused with CO-RBC 1 h after ischemia; and early CO-RBC group (n = 12), perfused with CO-RBC 30 min after ischemia. The reperfusion injuries were evaluated through anti-reactive oxygen species (ROS), inflammatory action, organ function, cell apoptosis and autophagy. Conclusions Carboxyhemoglobin not only relieves the oxidative injury and inhibites apoptosis and autophagy, but also aggravates inflammatory reactions during reperfusion. The action time of carboxyhemoglobin may be an influencing factor for reperfusion outcomes.
Collapse
Affiliation(s)
- Hongyu Liu
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
| | - Songyan Yu
- Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
| | - Yaojun Peng
- Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China
| | - Xin Chang
- Department of Clinical Laboratory, Weihai Municipal Hospital, Weihai 264200, Shandong, China
| | - Xinguang Yu
- Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
| |
Collapse
|
19
|
Khelifi I, Naret T, Renko D, Hamze A, Bernadat G, Bignon J, Lenoir C, Dubois J, Brion JD, Provot O, Alami M. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors. Eur J Med Chem 2016; 127:1025-1034. [PMID: 28166995 DOI: 10.1016/j.ejmech.2016.11.012] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Revised: 10/26/2016] [Accepted: 11/05/2016] [Indexed: 10/20/2022]
Abstract
The synthesis and evaluation of a new series of IsoCombretaQuinolines (IsoCoQuines) 2 with a 2-substituted-quinoline in place of the 3,4,5-trimethoxyphenyl ring present in isoCA-4 and CA-4 are described. Most of these compounds displayed a potent cytotoxic activity (IC50 < 10 nM) against a panel of five human cancer cell lines and inhibited tubulin assembly at a micromolar level. The most potent analogue 2b, having a 3-hydroxy-4-methoxyphenyl as B-ring, led to cell cycle arrest in G2/M phase. Docking studies indicate that 2b showed a binding mode comparable to those previously observed with quinazoline analogous (IsoCoQ) and with isoCA-4 at the colchicine binding site of tubulin.
Collapse
Affiliation(s)
- Ilhem Khelifi
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Timothée Naret
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Dolor Renko
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Abdallah Hamze
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Guillaume Bernadat
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Jérome Bignon
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS Avenue de La Terrasse, F-91198 Gif sur Yvette, France
| | - Christine Lenoir
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS Avenue de La Terrasse, F-91198 Gif sur Yvette, France
| | - Joëlle Dubois
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS Avenue de La Terrasse, F-91198 Gif sur Yvette, France
| | - Jean-Daniel Brion
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France
| | - Olivier Provot
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France.
| | - Mouad Alami
- BioCIS, Univ. Paris-Sud, CNRS, Université Paris-Saclay, 92290, Châtenay-Malabry, France.
| |
Collapse
|
20
|
Shi YW, Yuan W, Wang X, Gong J, Zhu SX, Chai LL, Qi JL, Qin YY, Gao Y, Zhou YL, Fan XL, Ji CY, Wu JY, Wang ZW, Liu D. Combretastatin A-4 efficiently inhibits angiogenesis and induces neuronal apoptosis in zebrafish. Sci Rep 2016; 6:30189. [PMID: 27452835 PMCID: PMC4958954 DOI: 10.1038/srep30189] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2016] [Accepted: 06/30/2016] [Indexed: 12/11/2022] Open
Abstract
Cis-stilbene combretastatin A-4 (CA-4) and a large group of its derivant compounds have been shown significant anti-angiogenesis activity. However the side effects even the toxicities of these chemicals were not evaluated adequately. The zebrafish model has become an important vertebrate model for evaluating drug effects. The testing of CA-4 on zebrafish is so far lacking and assessment of CA-4 on this model will provide with new insights of understanding the function of CA-4 on angiogenesis, the toxicities and side effects of CA-4. We discovered that 7-9 ng/ml CA-4 treatments resulted in developmental retardation and morphological malformation, and led to potent angiogenic defects in zebrafish embryos. Next, we demonstrated that intraperitoneal injection of 5, 10 and 20 mg/kg CA-4 obviously inhibited vessel plexus formation in regenerated pectoral fins of adult zebrafish. Interestingly, we proved that CA-4 treatment induced significant cell apoptosis in central nervous system of zebrafish embryos and adults. Furthermore, it was demonstrated that the neuronal apoptosis induced by CA-4 treatment was alleviated in p53 mutants. In addition, notch1a was up-regulated in CA-4 treated embryos, and inhibition of Notch signaling by DAPT partially rescued the apoptosis in zebrafish central nervous system caused by CA-4.
Collapse
Affiliation(s)
- Yun-Wei Shi
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Wei Yuan
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Xin Wang
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Jie Gong
- School of life science, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Shun-Xing Zhu
- Laboratory Animal Center, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Lin-Lin Chai
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Jia-Ling Qi
- School of medicine, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Yin-Yin Qin
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Yu Gao
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Yu-Ling Zhou
- School of medicine, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Xiao-Le Fan
- School of medicine, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Chun-Ya Ji
- School of medicine, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Jia-Yi Wu
- School of medicine, Nantong University, Nantong, Jiangsu 226001, PRC
| | - Zhi-Wei Wang
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC.,Department of Pharmacology, University of California, Irvine, CA 92697, USA
| | - Dong Liu
- Co-innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, PRC
| |
Collapse
|
21
|
Ghinet A, Moise IM, Rigo B, Homerin G, Farce A, Dubois J, Bîcu E. Studies on phenothiazines: New microtubule-interacting compounds with phenothiazine A-ring as potent antineoplastic agents. Bioorg Med Chem 2016; 24:2307-17. [PMID: 27073050 DOI: 10.1016/j.bmc.2016.04.001] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2016] [Revised: 03/29/2016] [Accepted: 04/01/2016] [Indexed: 10/22/2022]
Abstract
New phenothiazine derivatives 6-20 have been designed, synthesized and evaluated in vitro for their ability to inhibit tubulin polymerization and antiproliferative activity against 60 cancer cell lines, including several multi-drug resistant (MDR) tumor cell lines. The phenothiazine unit may successfully replace the classical 3,4,5-trimethoxyphenyle A ring of parent combretastatin A-4 or phenstatin, confirming previous studies. The most promising structural modulations have been realized on the B ring, the 2'-fluoro-4'-methoxy substitution in compound 6 and the 2'-trifluoromethyl-4'-methoxy substitution in compound 7 providing the best antitubulin and antitumor activity in the current study. Compounds 6-8 and 16 exhibited more important cell growth inhibition than parent phenstatin 2 on human colon Duke's type D, colorectal adenocarcinoma COLO 205 and on human kidney adenocarcinoma A498 cell lines. 10-Methylphenothiazine derivatives 19 and 20 did not show biological activity but exerted bright fluorescence and solvatochromism effects. These molecules deserve further chemical efforts in order to provide valuable tools for biophysical studies.
Collapse
Affiliation(s)
- Alina Ghinet
- Department of Organic Chemistry, 'Al. I. Cuza' University of Iasi, Faculty of Chemistry, Bd. Carol I nr. 11, 700506 Iasi, Romania; Inserm U995, LIRIC, Université de Lille, CHRU de Lille, Faculté de médecine-Pôle recherche, Place Verdun, F-59045 Lille Cedex, France; Hautes Etudes d'Ingénieur (HEI), Groupe HEI-ISA-ISEN, UCLille, Laboratoire de Pharmacochimie, 13 rue de Toul, F-59046 Lille, France
| | - Iuliana-Monica Moise
- Department of Organic Chemistry, 'Al. I. Cuza' University of Iasi, Faculty of Chemistry, Bd. Carol I nr. 11, 700506 Iasi, Romania
| | - Benoît Rigo
- Inserm U995, LIRIC, Université de Lille, CHRU de Lille, Faculté de médecine-Pôle recherche, Place Verdun, F-59045 Lille Cedex, France; Hautes Etudes d'Ingénieur (HEI), Groupe HEI-ISA-ISEN, UCLille, Laboratoire de Pharmacochimie, 13 rue de Toul, F-59046 Lille, France
| | - Germain Homerin
- Inserm U995, LIRIC, Université de Lille, CHRU de Lille, Faculté de médecine-Pôle recherche, Place Verdun, F-59045 Lille Cedex, France; Hautes Etudes d'Ingénieur (HEI), Groupe HEI-ISA-ISEN, UCLille, Laboratoire de Pharmacochimie, 13 rue de Toul, F-59046 Lille, France
| | - Amaury Farce
- Inserm U995, LIRIC, Université de Lille, CHRU de Lille, Faculté de médecine-Pôle recherche, Place Verdun, F-59045 Lille Cedex, France; Faculté des Sciences Pharmaceutiques et Biologiques de Lille, 3 Rue du Pr Laguesse, B.P. 83, F-59006 Lille, France
| | - Joëlle Dubois
- Institut de Chimie des Substances Naturelles, UPR2301 CNRS, Centre de Recherche de Gif, Avenue de la Terrasse, F-91198 Gif-sur-Yvette Cedex, France
| | - Elena Bîcu
- Department of Organic Chemistry, 'Al. I. Cuza' University of Iasi, Faculty of Chemistry, Bd. Carol I nr. 11, 700506 Iasi, Romania.
| |
Collapse
|
22
|
Ma ZL, Yan XJ, Zhao L, Zhou JJ, Pang W, Kai ZP, Wu FH. Combretastatin A-4 and Derivatives: Potential Fungicides Targeting Fungal Tubulin. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2016; 64:746-751. [PMID: 26711170 DOI: 10.1021/acs.jafc.5b05119] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Combretastatin A-4, first isolated from the African willow tree Combretum caffrum, is a tubulin polymerization inhibitor in medicine. It was first postulated as a potential fungicide targeting fungal tubulin for plant disease control in this study. Combretastatin A-4 and its derivatives were synthesized and tested against Rhizoctonia solani and Pyricularia oryzae. Several compounds have EC50 values similar to or better than that of isoprothiolane, which is widely used for rice disease control. Structure-activity relationship study indicated the the cis configuration and hydroxyl group in combretastatin A-4 are crucial to the antifungal effect. Molecular modeling indicated the binding sites of combretastatin A-4 and carbendazim on fungal tubulin are totally different. The bioactivity of combretastatin A-4 and its derivatives against carbendazim-resistant strains was demonstrated in this study. The results provide a new approach for fungicide discovery and fungicide resistance management.
Collapse
Affiliation(s)
- Zhong-lin Ma
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
| | - Xiao-jing Yan
- Institute of Plant Protection, China Academy of Agricultural Sciences , Beijing 100193, People's Republic of China
| | - Lei Zhao
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
| | - Jiu-jiu Zhou
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
| | - Wan Pang
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
| | - Zhen-peng Kai
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
| | - Fan-hong Wu
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology , Shanghai 201418, People's Republic of China
- Shanghai Engineering Research Center of Pharmaceutical Progress , Shanghai 201203, People's Republic of China
| |
Collapse
|
23
|
Jung Y, Kim I. Chemoselective reduction of quinols as an alternative to Sonogashira coupling: synthesis of polysubstituted benzofurans. Org Biomol Chem 2016; 14:10454-10472. [DOI: 10.1039/c6ob01941b] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
An efficient synthetic approach to polysubstituted benzofurans is described, using 2-methoxyquinone as a benzofuran backbone.
Collapse
Affiliation(s)
- Youngeun Jung
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences
- Yonsei University
- Incheon
- Republic of Korea
| | - Ikyon Kim
- College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences
- Yonsei University
- Incheon
- Republic of Korea
| |
Collapse
|
24
|
Lawson M, Bignon J, Brion JD, Hamze A, Alami M. Transition-Metal-Free Synthesis of Polysubstituted Cyclopropane Derivatives fromN-Tosylhydrazones and their Cytotoxic Activities. ASIAN J ORG CHEM 2015. [DOI: 10.1002/ajoc.201500289] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Marie Lawson
- Univ Paris-Sud, CNRS, BioCIS UMR 8076; Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie; 5 rue J-B Clément 92296 Châtenay-Malabry France
| | - Jérôme Bignon
- Institut de Chimie des Substances Naturelles; UPR 2301, CNRS; Avenue de la Terrasse. F-92296 Gif-sur-Yvette France
| | - Jean-Daniel Brion
- Univ Paris-Sud, CNRS, BioCIS UMR 8076; Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie; 5 rue J-B Clément 92296 Châtenay-Malabry France
| | - Abdallah Hamze
- Univ Paris-Sud, CNRS, BioCIS UMR 8076; Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie; 5 rue J-B Clément 92296 Châtenay-Malabry France
| | - Mouad Alami
- Univ Paris-Sud, CNRS, BioCIS UMR 8076; Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie; 5 rue J-B Clément 92296 Châtenay-Malabry France
| |
Collapse
|
25
|
Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins. Eur J Med Chem 2015; 100:210-22. [DOI: 10.1016/j.ejmech.2015.05.047] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 05/19/2015] [Accepted: 05/31/2015] [Indexed: 01/05/2023]
|
26
|
Soussi MA, Provot O, Bernadat G, Bignon J, Desravines D, Dubois J, Brion JD, Messaoudi S, Alami M. IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity. ChemMedChem 2015; 10:1392-402. [PMID: 26076053 DOI: 10.1002/cmdc.201500069] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Revised: 05/19/2015] [Indexed: 01/06/2023]
Abstract
A series of novel isocombretaquinazolines (isoCoQ) 4 were quickly prepared by coupling N-toluenesulfonylhydrazones with 4-chloroquinazolines under palladium catalysis. These compounds, which can be regarded as isocombretastatin A-4 (isoCA-4) analogues that lack the 3,4,5-trimethoxyphenyl ring, displayed nanomolar-level cytotoxicity against various human cancer cell lines and were observed to effectively inhibit tubulin polymerization. The isoCoQ compounds 2-methoxy-5-(1-(2-methylquinazolin-4-yl)vinyl)phenol (4 b), 4-[1-(3-fluoro-4-methoxyphenyl)vinyl]-2-methylquinazoline (4 c), and 2-methoxy-5-(1-(2-methylquinazolin-4-yl)vinyl)aniline (4 d), which respectively bear the greatest resemblance to isoCA-4, isoFCA-4, and isoNH2 CA-4, are able to arrest HCT116 cancer cells in the G2 /M cell-cycle phase at very low concentrations. Preliminary in vitro antivascular assay results show that 4 d is able to disrupt a network of capillary-like structures formed by human umbilical vein endothelial cells on Matrigel. All these results clearly demonstrate that replacement of the 3,4,5-trimethoxyphenyl ring of isoCA-4 with a quinazoline nucleus is a feasible approach toward new and highly promising derivatives with the potential for further development as antitubulin agents.
Collapse
Affiliation(s)
- Mohamed Ali Soussi
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France)
| | - Olivier Provot
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France).
| | - Guillaume Bernadat
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France)
| | - Jérome Bignon
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la Terrasse, 91198 Gif-sur-Yvette (France)
| | - Déborah Desravines
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la Terrasse, 91198 Gif-sur-Yvette (France)
| | - Joëlle Dubois
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la Terrasse, 91198 Gif-sur-Yvette (France)
| | - Jean-Daniel Brion
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France)
| | - Samir Messaoudi
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France).
| | - Mouad Alami
- Univ. Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 rue J.-B. Clément, Châtenay-Malabry, 92296 (France).
| |
Collapse
|
27
|
Roche M, Salim SM, Bignon J, Levaique H, Brion JD, Alami M, Hamze A. Palladium-Catalyzed One-Pot Reaction of Hydrazones, Dihaloarenes, and Organoboron Reagents: Synthesis and Cytotoxic Activity of 1,1-Diarylethylene Derivatives. J Org Chem 2015; 80:6715-27. [PMID: 26036279 DOI: 10.1021/acs.joc.5b00880] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A new three-component assembly reaction between N-tosylhydrazones, dihalogenated arenes, and boronic acids or boronate esters was developed, producing highly substituted 1,1-diarylethylenes in good yields. The two C-C bonds formed through this coupling have been catalyzed by a single Pd-catalyst in a one-pot fashion. It is noted that the one-pot pinacol boronate cross-coupling reaction generally provides products in high yields, offers an expansive substrate scope, and can address a broad range of aryl, styrene, vinyl, and heterocyclic olefinic targets. The scope of this one-pot coupling has been also extended to the synthesis of the 1,1-diarylethylene skeleton of the natural product ratanhine. The new compounds were evaluated for their cytotoxic activity, and this allowed the identification of compound 4ab that exhibits excellent antiproliferative activity in the nanomolar concentration range against HCT116 cancer cell lines.
Collapse
Affiliation(s)
- Maxime Roche
- †Université Paris-Sud, CNRS, BioCIS-UMR 8076, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, rue J.-B. Clément, F-92296 Châtenay-Malabry, France
| | - Salim Mmadi Salim
- †Université Paris-Sud, CNRS, BioCIS-UMR 8076, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, rue J.-B. Clément, F-92296 Châtenay-Malabry, France
| | - Jérôme Bignon
- ‡Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la Terrasse, F-91198 Gif sur Yvette, France
| | - Hélène Levaique
- ‡Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, avenue de la Terrasse, F-91198 Gif sur Yvette, France
| | - Jean-Daniel Brion
- †Université Paris-Sud, CNRS, BioCIS-UMR 8076, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, rue J.-B. Clément, F-92296 Châtenay-Malabry, France
| | - Mouad Alami
- †Université Paris-Sud, CNRS, BioCIS-UMR 8076, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, rue J.-B. Clément, F-92296 Châtenay-Malabry, France
| | - Abdallah Hamze
- †Université Paris-Sud, CNRS, BioCIS-UMR 8076, Equipe Labellisée Ligue Contre le Cancer, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, rue J.-B. Clément, F-92296 Châtenay-Malabry, France
| |
Collapse
|
28
|
Renko D, Provot O, Rasolofonjatovo E, Bignon J, Rodrigo J, Dubois J, Brion JD, Hamze A, Alami M. Rapid synthesis of 4-arylchromenes from ortho-substituted alkynols: A versatile access to restricted isocombretastatin A-4 analogues as antitumor agents. Eur J Med Chem 2015; 90:834-44. [DOI: 10.1016/j.ejmech.2014.12.024] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2014] [Revised: 12/11/2014] [Accepted: 12/13/2014] [Indexed: 01/12/2023]
|
29
|
Soussi MA, Provot O, Bernadat G, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Messaoudi S, Alami M. Discovery of azaisoerianin derivatives as potential antitumors agents. Eur J Med Chem 2014; 78:178-89. [DOI: 10.1016/j.ejmech.2014.03.032] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2014] [Revised: 03/11/2014] [Accepted: 03/12/2014] [Indexed: 01/05/2023]
|
30
|
Sanghai N, Jain V, Preet R, Kandekar S, Das S, Trivedi N, Mohapatra P, Priyadarshani G, Kashyap M, Das D, Satapathy SR, Siddharth S, Guchhait SK, Kundu CN, Bharatam PV. Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents. MEDCHEMCOMM 2014. [DOI: 10.1039/c3md00357d] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines that exhibit potent tubulin polymerization inhibition, anticancer activity, anti-migration of cancer cells, chromosomal damage, and apoptosis have been developed.
Collapse
Affiliation(s)
- Nitesh Sanghai
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | - Vaibhav Jain
- Department of Pharmacoinformatics
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | - Ranjan Preet
- School of Biotechnology, KIIT University
- Bhubaneswar, India
| | - Somnath Kandekar
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | - Sarita Das
- School of Biotechnology, KIIT University
- Bhubaneswar, India
| | - Neha Trivedi
- Department of Pharmacoinformatics
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | | | - Garima Priyadarshani
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | - Maneesh Kashyap
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | - Dipon Das
- School of Biotechnology, KIIT University
- Bhubaneswar, India
| | | | | | - Sankar K. Guchhait
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
| | | | - Prasad V. Bharatam
- Department of Medicinal Chemistry
- National Institute of Pharmaceutical Education and Research (NIPER)
- S. A. S. Nagar (Mohali), India
- Department of Pharmacoinformatics
- National Institute of Pharmaceutical Education and Research (NIPER)
| |
Collapse
|
31
|
Rasolofonjatovo E, Provot O, Hamze A, Rodrigo J, Bignon J, Wdzieczak-Bakala J, Lenoir C, Desravines D, Dubois J, Brion JD, Alami M. Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted iso combretastatin A-4 analogs. Eur J Med Chem 2013; 62:28-39. [DOI: 10.1016/j.ejmech.2012.12.042] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2012] [Revised: 12/18/2012] [Accepted: 12/23/2012] [Indexed: 11/29/2022]
|
32
|
Palladium-Catalyzed Cross-Coupling Reaction of Thioglycosides with (Hetero)aryl Halides. Adv Synth Catal 2013. [DOI: 10.1002/adsc.201200695] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
33
|
Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents. Eur J Med Chem 2013; 60:305-24. [DOI: 10.1016/j.ejmech.2012.12.008] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2012] [Revised: 11/27/2012] [Accepted: 12/05/2012] [Indexed: 12/22/2022]
|
34
|
Lawson M, Hamze A, Peyrat JF, Bignon J, Dubois J, Brion JD, Alami M. An efficient coupling of N-tosylhydrazones with 2-halopyridines: synthesis of 2-α-styrylpyridines endowed with antitumor activity. Org Biomol Chem 2013; 11:3664-73. [DOI: 10.1039/c3ob40263k] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
35
|
Abuhaie CM, Bîcu E, Rigo B, Gautret P, Belei D, Farce A, Dubois J, Ghinet A. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents. Bioorg Med Chem Lett 2013. [DOI: 10.1016/j.bmcl.2012.10.135] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Roche M, Hamze A, Brion JD, Alami M. Catalytic Three-Component One-Pot Reaction of Hydrazones, Dihaloarenes, and Amines. Org Lett 2012; 15:148-51. [DOI: 10.1021/ol303194s] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Maxime Roche
- Univ Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| | - Abdallah Hamze
- Univ Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| | - Jean-Daniel Brion
- Univ Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| | - Mouad Alami
- Univ Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| |
Collapse
|
37
|
Aziz J, Brachet E, Hamze A, Peyrat JF, Bernadat G, Morvan E, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Tueni M, Yassine A, Brion JD, Alami M. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors. Org Biomol Chem 2012; 11:430-42. [PMID: 23047722 DOI: 10.1039/c2ob26253c] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The synthesis and structure-activity relationships associated with a series of 1,1-diarylethylene tubulin polymerization inhibitors 3 and 4 are described. The key step for their preparation involves a palladium-catalyzed coupling of N-arylsulfonylhydrazones with aryl halides, thus providing flexible and convergent access to tri- and tetrasubstituted 1,1-diarylolefins 3 and 4 related to isocombretastatin A-4 (isoCA-4). These compounds have been evaluated for tubulin polymerization inhibitory activity as well as for cytotoxic activity. The most potent compounds are 1,1-diaryl-2-methoxyethylenes 4b, 4d and 4e having a trisubstituted double bond. They exhibited good antiproliferative activity against various human cancer cell lines (GI(50) = 8-80 nM). Compounds 4b and 4e strongly inhibited tubulin polymerization with IC(50) values of 2 and 3 μM, respectively, and induced cell cycle arrest in the G(2)/M phase in the K562 cell line. Docking studies in the colchicine binding site of tubulin allowed identification of residues most likely to interact with these inhibitors and explain their potent anti-tubulin activity.
Collapse
Affiliation(s)
- Jessy Aziz
- Université Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, 5 rue J-B Clément, Châtenay-Malabry, F-92296, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Rasolofonjatovo E, Provot O, Hamze A, Rodrigo J, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Alami M. Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity. Eur J Med Chem 2012; 52:22-32. [DOI: 10.1016/j.ejmech.2012.03.001] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2012] [Revised: 02/28/2012] [Accepted: 03/01/2012] [Indexed: 11/29/2022]
|
39
|
Hamze A, Brion JD, Alami M. Synthesis of 1,1-Diarylethylenes via Efficient Iron/Copper Co-Catalyzed Coupling of 1-Arylvinyl Halides with Grignard Reagents. Org Lett 2012; 14:2782-5. [DOI: 10.1021/ol3010112] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Abdallah Hamze
- Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, Université Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| | - Jean-Daniel Brion
- Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, Université Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| | - Mouad Alami
- Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie, Université Paris-Sud, CNRS, BioCIS UMR 8076, LabEx LERMIT, 5 Rue J. B. Clément, Châtenay-Malabry, F-92296, France
| |
Collapse
|
40
|
Alami M. Author profile. Mouâd Alami. ChemMedChem 2012; 7:193. [PMID: 22170732 DOI: 10.1002/cmdc.201100495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
41
|
Rasolofonjatovo E, Tréguier B, Provot O, Hamze A, Brion JD, Alami M. A One-Pot Three-Step Synthesis of Z-Trisubstituted Olefins from Arylalkynes and Their Cyclization into 4-Aryl-2H-chromenes. European J Org Chem 2012. [DOI: 10.1002/ejoc.201101735] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|